GPT Healthcare Limited has notified the stock exchanges of an upcoming Board of Directors meeting scheduled for Monday, May 18, 2026, at its registered office located at GPT Centre, JC-25, Sector III, Salt Lake, Kolkata – 700 106. The intimation has been filed pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Board Meeting Agenda

The board meeting has been convened to consider and approve the following key matters:

• Audited Financial Results along with the Report of the Statutory Auditors for the 4th quarter and financial year ended March 31, 2026
• Recommendation of final dividend, if any, on the equity share capital of the company for FY 2025-26

The key details of the scheduled board meeting are summarised below:

Trading Window Closure

In continuation of the company's earlier communication dated March 26, 2026, regarding the closure of the trading window, GPT Healthcare has confirmed that the trading window for dealing in the company's securities will remain closed until May 20, 2026. The closure will remain in effect until the expiry of 48 hours after the unpublished price-sensitive information is submitted to the stock exchanges, in accordance with the company's Code of Conduct for Prevention of Insider Trading.

The notice has been made available on the company's website at https://ilshospitals.com . The intimation was signed by Ankur Sharma, Company Secretary and Compliance Officer (M. No. A31833), on May 11, 2026.

GPT Healthcare Limited has submitted its quarterly compliance certificate under SEBI regulations for the quarter ended March 31, 2026. The filing, dated April 10, 2026, was communicated to both BSE and NSE as part of mandatory regulatory compliance requirements.

Regulatory Compliance Certificate

The certificate was issued under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018. MUFG Intime India Private Limited, formerly known as Link Intime India Private Limited, served as the registrar and transfer agent for this compliance requirement.

Certificate Confirmation

MUFG Intime India Private Limited confirmed in their certificate dated April 2, 2026, that no requests for dematerialization or rematerialization of shares were received during the quarter ended March 31, 2026. The certificate was signed by Ashok Shetty, Vice President – Corporate Registry.

Company Details

GPT Healthcare Limited maintains its registered office at GPT Centre, JC-25, Sector III, Salt Lake, Kolkata. The company secretary and compliance officer, Ankur Sharma, digitally signed the submission on April 10, 2026.

This quarterly filing represents routine compliance with SEBI regulations governing depositories and participants, ensuring transparency in share transfer activities for listed companies.